Experience |
Ongoing Projects / Studies / Contracts
CAPACITY BUILDING
ARCEAU-RDC: Alliance for Clinical Research and Clinical Epidemiology in the DRC / Alliance pour la recherche clinique & épidémiologie clinique
Expansion and promotion of clinical research capacities in collaboration with two partner organizations in Kinshasa, Democratic Republic of Congo (Kinshasa School of Public Health and Biamba Marie Mutombo Hospital).
Role of MedRes: The activities include the construction / renovation of laboratories, creation of quality assurance system, staff training (see: www.arceau-rdc.org)
Countries: Democratic Republic of Congo
Source of monetary support: Bill & Melinda Gates Foundation
HATCap: Trial capacity platform for Human African Trypanosomiasis (HAT, sleeping sickness) in Africa
Role of MedRes: Contribution to clinical trial methodology development, laboratory improvement, strengthening & harmonisation of regulatory practices throughout the region affected by HAT
Countries: Angola, Central Africa Republic, Democratic Republic of Congo, Republic of Congo, South Sudan, Uganda
Source of monetary support: Drugs for Neglected Diseases initiative (DNDi)
ARCEAU-RDC : Alliance for Clinical Research and Clinical Epidemiology in the Democratic Republic of Congo / Alliance pour la recherche clinique & épidémiologie clinique
INVESTIGATOR DRIVEN CLINICAL TRIALS
None
SHORT TERM CONSULTANCIES
None
Past Projects / Studies / Contracts
CAPACITY BUILDING
Reference center for human African trypanosomiasis (HAT), ICCT Angola: Development of a reference structure (laboratories, clinic) for the diagnosis and treatment of HAT (sleeping sickness)
Role of MedRes: Conceptional work, fundraising, procurement, implementation
Country: Angola
Source of monetary support: Swiss Agency for Development & Cooperation (SDC), Norwegian Peoples Aid, Ministry of Foreign Affairs, France
Reference center for human African trypanosomiasis (HAT), BCT Democratic Republic of the Congo:
Development of a reference structure (laboratories, clinic) for the diagnosis and treatment of HAT (sleeping sickness)
Role of MedRes: Conceptional work, fundraising, procurement, implementation
Country: Democratic Republic of the Congo
Source of monetary support: Swiss Agency for Development & Cooperation (SDC), Bureau Central de la Trypanosomiase (BCT) Democratic Republic of the Congo
INVESTIGATOR DRIVEN CLINICAL TRIALS
IMPAMEL I: Abbreviated melarsoprol regimen for second stage Human African Trypanosomiasis (sleeping sickness), Phase III, 500 patients
Country: Angola
Source of monetary support: Swiss Agency for Development & Cooperation (SDC)
Sponsor: Swiss Tropical & Public Health Institute
IMPAMEL II: Abbreviated melarsoprol regimen for second stage Human African Trypanosomiasis (sleeping sickness), Phase IIIb effectiveness study, 2’500 patients
Countries: Ivory Coast, Democratic Republic of the Congo, Angola, Uganda, South Sudan, Central African Republic, Equatorial Guinea, Republic of Congo
Source of monetary support: Swiss Agency for Development & Cooperation (SDC)
Sponsor: Swiss Tropical & Public Health Institute
IMPAMEL III: Abbreviated melarsoprol regimen for second stage Human African Trypanosomiasis (sleeping sickness) T.b. rhodesiense form, Phase II - Proof of concept & drug utilization trials, total 120 patients
Countries: Uganda, Tanzania
Source of monetary support: Swiss Agency for Development & Cooperation (SDC), Swiss Tropical & Public Health Institute
Sponsor: Swiss Tropical & Public Health Institute
SHORT TERM CONSULTANCIES
Project Review - Mid-term project review in several public health institutions in the Democratic Republic of Congo (DRC) (Directorate General for Development Cooperation, Belgium)
Role of MedRes: Conduct of review
Country: Democratic Republic of Congo
Mandator: Directorate General for Development Cooperation, Belgium – through Swiss Centre for International Health
For further information of MedRes experience see also: